✨ Medicines Notices




10 JUNE 2010

NEW ZEALAND GAZETTE, No. 64

1855


Product:

Fluconazole
Active Ingredient: Fluconazole 2mg/mL
Dosage Form: Solution for infusion
New Zealand Sponsor: Baxter Healthcare Limited
Manufacturer: Baxter Healthcare of Puerto Rico, Jayuya, Puerto Rico


Product:

Jurnista
Active Ingredient: Hydromorphone hydrochloride 4mg
Dosage Form: Modified release tablet
New Zealand Sponsor: Janssen-Cilag (New Zealand) Limited
Manufacturer: Alza Corporation, Vacaville, United States of America


Product:

Sensodyne Pronamel
Active Ingredients: Potassium nitrate 50mg/g
Sodium fluoride 2.21mg/g
Dosage Form: Toothpaste
New Zealand Sponsor: GlaxoSmithKline (NZ) Limited
Manufacturer: GlaxoSmithKline Australia Pty Limited, Ermington, Australia

Dated this 3rd day of June 2010.

STEWART JESSAMINE, Acting Deputy Director-General, Regulation and Governance Directorate, Ministry of Health
(pursuant to delegation given by the Minister of Health on 6 July 2001).

go4427


Renewal of Provisional Consent to the Distribution of Medicines

Pursuant to section 23(4A) of the Medicines Act 1981, the Minister of Health hereby renews the provisional consent to the sale, supply or use in New Zealand of the medicines set out in the Schedule hereto:

Schedule

Product:

Bicillin L-A
Active Ingredient: Benzathine benzylpenicillin tetrahydrate 450mg/mL
Dosage Form: Suspension for injection
New Zealand Sponsor: Pharmacy Retailing (NZ) Limited t/a Healthcare Logistics
Manufacturers: Wyeth Pharmaceuticals Inc, West Chester, United States of America
King Pharmaceuticals Inc, Rochester, United States of America

Note: This renewed consent is valid for two years from 7 August 2010.


Product:

Potassium 10mmol
Active Ingredient: Potassium chloride 7.385g/L
Dosage Form: Solution for infusion
New Zealand Sponsor: Baxter Healthcare Limited
Manufacturer: Baxter Healthcare Pty Limited, Old Toongabbie, Australia

Note: This renewed consent is valid for two years from 12 June 2010.


Product:

Potassium 40mmol
Active Ingredient: Potassium chloride 2.95g/L
Dosage Form: Solution for infusion
New Zealand Sponsor: Baxter Healthcare Limited
Manufacturer: Baxter Healthcare Pty Limited, Old Toongabbie, Australia

Note: This renewed consent is valid for two years from 12 June 2010.

Dated this 3rd day of June 2010.

STEWART JESSAMINE, Acting Deputy Director-General, Regulation and Governance Directorate, Ministry of Health
(pursuant to delegation given by the Minister of Health on 6 July 2001).

go4430


Misuse of Drugs Act 1975

Capital Coast District Health Board’s Opioid Treatment Service

Places at Which Controlled Drugs May be Prescribed, Administered, or Supplied for the Purpose of Treating People with Drug Dependence

Pursuant to section 24(7)(b) of the Misuse of Drugs Act 1975, the places at which controlled drugs may be prescribed, administered, or supplied for the purposes of that section, subject to the agreed conditions.

DAVID CHAPLOW (DR), Director of Mental Health, acting under delegated authority from the Minister of Health, specify that the places operated by

Dated at Wellington this 27th day of May 2010.

go4259



Next Page →



Online Sources for this page:

Gazette.govt.nz PDF NZ Gazette 2010, No 64





✨ LLM interpretation of page content

πŸ₯ Consent to Distribution of New Medicines

πŸ₯ Health & Social Welfare
3 June 2010
Medicines Act, Consent, Fluconazole, Jurnista, Sensodyne Pronamel
  • STEWART JESSAMINE, Acting Deputy Director-General, Regulation and Governance Directorate, Ministry of Health

πŸ₯ Renewal of Provisional Consent to Distribution of Medicines

πŸ₯ Health & Social Welfare
3 June 2010
Medicines Act, Renewal, Bicillin L-A, Potassium 10mmol, Potassium 40mmol
  • STEWART JESSAMINE, Acting Deputy Director-General, Regulation and Governance Directorate, Ministry of Health

πŸ₯ Places for Controlled Drugs Prescription and Administration

πŸ₯ Health & Social Welfare
27 May 2010
Misuse of Drugs Act, Opioid Treatment, Controlled Drugs
  • DAVID CHAPLOW (DR), Director of Mental Health